Sundar.M
☆    

India,
2019-02-15 14:37
(2330 d 14:01 ago)

Posting: # 19925
Views: 2,531
 

 Dose curve [PK / PD]

Post reply
Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
 
UA Flag
Activity
 Admin contact
23,426 posts in 4,929 threads, 1,681 registered users;
34 visitors (0 registered, 34 guests [including 9 identified bots]).
Forum time: 05:39 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5